Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a stem cell transplant in the womb stop fanconi anemia?

NCT ID NCT07408583

First seen Feb 14, 2026 · Last updated May 23, 2026 · Updated 14 times

Summary

This study tests whether giving a stem cell transplant to a fetus with Fanconi Anemia (a rare genetic disorder that causes bone marrow failure and cancer risk) is safe and can help control the disease. About 12 pregnant women carrying an affected fetus will receive the experimental treatment between 19 and 28 weeks of pregnancy. The goal is to see if early treatment can reduce the need for lifelong medications, though ongoing management may still be needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENETIC DISEASES, INBORN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stanford University

    Stanford, California, 94305, United States

  • University of California, San Francisco

    San Francisco, California, 94143, United States

Conditions

Explore the condition pages connected to this study.